Macom price target lowered to $95 from $100 at Craig-Hallum

Craig-Hallum lowered the firm’s price target on Macom to $95 from $100 and keeps a Buy rating on the shares. Macom’s Q1 organic results were close to consensus and Q2 EPS and sales were guided at or slightly below consensus, the analyst tells investors in a research note. The firm likes this name for a cycle play and for a long-term investment in a well-diversified, well-run company.